Inven2 is the tech transfer office at Oslo University Hospital, University of Oslo and South-Eastern Norway Regional Health Authority, the largest tech transfer office in Norway.
The "Idéprisen 2012" offers the opportunity to win NOK 100 000 to take your business idea further.
Deadline for submission is 12 October 2012.
From major journals, first or last author from the Institute for Cancer Research
Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy
Ann Oncol (in press)
GRP94 rewires and buffers the FLT3-ITD signaling network and promotes survival of acute myeloid leukemic stem cells
Haematologica, 104 (5), e229
Transient redirection of T cells for adoptive cell therapy with telomerase-specific T helper cell receptors isolated from long term survivors after cancer vaccination
Oncoimmunology, 8 (4), e1565236